Literature DB >> 1651421

The hepatitis A virus polyprotein expressed by a recombinant vaccinia virus undergoes proteolytic processing and assembly into viruslike particles.

P L Winokur1, J H McLinden, J T Stapleton.   

Abstract

Hepatitis A virus (HAV) contains a single-stranded, plus-sense RNA genome with a single long open reading frame encoding a polyprotein of approximately 250 kDa. Viral structural proteins are generated by posttranslational proteolytic processing of this polyprotein. We constructed recombinant vaccinia viruses which expressed the HAV polyprotein (rV-ORF) and the P1 structural region (rV-P1). rV-ORF-infected cell lysates demonstrated that the polyprotein was cleaved into immunoreactive 29- and 33-kDa proteins which comigrated with HAV capsid proteins VP0 and VP1. The rV-P1 construct produced a 90-kDa protein which showed no evidence of posttranslational processing. Solid-phase radioimmunoassays with human polyclonal anti-HAV sera and with murine or human neutralizing monoclonal anti-HAV antibodies recognized the rV-ORF-infected cell lysates. Sucrose density gradients of rV-ORF-infected cell lysates contained peaks of HAV antigen with sedimentation coefficients of approximately 70S and 15S, similar to those of HAV empty capsids and pentamers. Immune electron microscopy also demonstrated the presence of viruslike particles in rV-ORF-infected cell lysates. Thus, the HAV polyprotein expressed by a recombinant vaccinia virus demonstrated posttranslational processing into mature capsid proteins which assembled into antigenic viruslike particles.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651421      PMCID: PMC248966     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Immunogenicity of a killed hepatitis A vaccine in seronegative volunteers.

Authors:  B Flehmig; U Heinricy; M Pfisterer
Journal:  Lancet       Date:  1989-05-13       Impact factor: 79.321

2.  Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication.

Authors:  S Kuge; A Nomoto
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

3.  Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus.

Authors:  L H Ping; R W Jansen; J T Stapleton; J I Cohen; S M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

4.  Neutralizing monoclonal antibodies to hepatitis A virus: partial localization of a neutralizing antigenic site.

Authors:  J V Hughes; L W Stanton; J E Tomassini; W J Long; E M Scolnick
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

5.  Infectious hepatitis A virus particles produced in cell culture consist of three distinct types with different buoyant densities in CsCl.

Authors:  S M Lemon; R W Jansen; J E Newbold
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

6.  Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans.

Authors:  J S Mao; D X Dong; H Y Zhang; N L Chen; X Y Zhang; H Y Huang; R Y Xie; T J Zhou; Z J Wan; Y Z Wang
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

7.  Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector.

Authors:  T Urakawa; M Ferguson; P D Minor; J Cooper; M Sullivan; J W Almond; D H Bishop
Journal:  J Gen Virol       Date:  1989-06       Impact factor: 3.891

8.  Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.

Authors:  E A Emini; J V Hughes; D S Perlow; J Boger
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

9.  Neutralizing antibody to hepatitis A virus in immune serum globulin and in the sera of human recipients of immune serum globulin.

Authors:  J T Stapleton; R Jansen; S M Lemon
Journal:  Gastroenterology       Date:  1985-09       Impact factor: 22.682

10.  Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus.

Authors:  J T Stapleton; S M Lemon
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

View more
  9 in total

1.  Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles.

Authors:  J T Stapleton; V Raina; P L Winokur; K Walters; D Klinzman; E Rosen; J H McLinden
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

2.  Hepatitis A viruses with deletions in the 2A gene are infectious in cultured cells and marmosets.

Authors:  S A Harmon; S U Emerson; Y K Huang; D F Summers; E Ehrenfeld
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

3.  Physiochemical and immunological characterization of hepatitis A virus nucleocapsids expressed in a vaccinia virus/T7/EMCV system.

Authors:  N L Zhu; G D Li; Y Wang
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

4.  Hepatitis A virus capsid protein VP1 has a heterogeneous C terminus.

Authors:  J Graff; O C Richards; K M Swiderek; M T Davis; F Rusnak; S A Harmon; X Y Jia; D F Summers; E Ehrenfeld
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

5.  Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins.

Authors:  M E Hagensee; N Yaegashi; D A Galloway
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

6.  Synthesis and assembly of hepatitis A virus-specific proteins in BS-C-1 cells.

Authors:  S V Borovec; D A Anderson
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  Recombinant hepatitis A virus antigen: improved production and utility in diagnostic immunoassays.

Authors:  F D LaBrecque; D R LaBrecque; D Klinzman; S Perlman; J B Cederna; P L Winokur; J Q Han; J T Stapleton
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

8.  Processing of proteinase precursors and their effect on hepatitis A virus particle formation.

Authors:  C Probst; M Jecht; V Gauss-Müller
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

9.  Improving virus production through quasispecies genomic selection and molecular breeding.

Authors:  Francisco J Pérez-Rodríguez; Lucía D'Andrea; Montserrat de Castellarnau; Maria Isabel Costafreda; Susana Guix; Enric Ribes; Josep Quer; Josep Gregori; Albert Bosch; Rosa M Pintó
Journal:  Sci Rep       Date:  2016-11-03       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.